Company intelligence / Profile preview

Oak Crest Institute of Science

Monrovia, California, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Oak Crest Institute of Science has developed an HIV prevention technology using a vaginal ring platform for drug delivery that entered Phase 1 clinical trials in 2020, supported by multiple rounds of NIH funding.[1]

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeBiologicVaccine
Industry: Academic Hospital/University/Research

Partnerships

National Institutes of Health (NIH) grant-funded collaborations on HIV prevention and drug-delivery technologies[1]National Science Foundation (NSF) grant support for research programs[1]City of Monrovia and Newton World Enterprises via the Monrovia–Oak Crest Science and Technology Incubator Program (MOST-IP)[7]

Beyond the preview

Go deeper on Oak Crest Institute of Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oak Crest Institute of Science.

Explore the full profile